Exploring novel and experimental combinations of anti-cancer substances to unlock powerful synergies and improve treatment outcomes
Subscribe to:
Comments (Atom)
-
Drug Repurposing in Cancer Treatment Discovering New Uses for Existing Clinically Approved Drugs ...
-
Sodium Phenylbutyrate: Redefining Therapeutic Potential Through Epigenetic Modulation Sodium Phenylbutyrate...
-
Fasting has long been recognized as a natural strategy for enhancing health, with numerous studies demonstrating its benefits for inhibiting...
-
Repurposing non-oncology drugs for cancer treatment has become an area of increasing interest. In particular, combinations of well-known pha...
-
Lung cancer driven by KRAS mutations, particularly the G12C variant, remains a significant challenge in non-small cell lung cancer (NSCLC) t...
Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity
ReplyDeletehttps://pubmed.ncbi.nlm.nih.gov/36727944/
From the authors: “This study demonstrates increased renal toxicity, injury and fibrosis in mice with lung cancer, which is exacerbated with cisplatin treatment. These results highlight the necessity of using preclinical models that more accurately capture the altered physiology of patients with cancer treated with cisplatin.”
DeletePersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
ReplyDeletehttps://www.nature.com/articles/s41586-023-06063-y
Immune Checkpoint Inhibitor Market : A Thriving Sector Set to Hit USD 155.1 billion by 2031
ReplyDeletehttps://www.openpr.com/news/3079854/immune-checkpoint-inhibitor-market-a-thriving-sector-set-to-hit
Potent anti-cancer therapy created using ‘click chemistry’
ReplyDeletehttps://www.ucl.ac.uk/news/2023/jul/potent-anti-cancer-therapy-created-using-click-chemistry
Your Cancer Cure May Already Exist
ReplyDeletehttps://www.nagourneycancerinstitute.com/post/your-cancer-cure-may-already-exist
How Does Functional Profiling Work?
DeleteThe process is quite straightforward yet profoundly revolutionary. It involves testing a patient’s living cells against a range of cancer drugs and combinations. This data is then compared with more than 10,000 patient studies in the database to determine the treatment most likely to succeed.
https://www.nagourneycancerinstitute.com/
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
ReplyDeletehttps://www.nature.com/articles/s41586-023-06073-w
https://www.uza.be/uza-foundation/projecten/car-t-celtherapie
ReplyDeleteStudy finds hallmarks of T cell exhaustion within hours of tumor exposure
ReplyDeletehttps://news.vumc.org/2023/08/03/study-finds-hallmarks-of-t-cell-exhaustion-within-hours-of-tumor-exposure/
Targeting innate immune pathways for cancer immunotherapy
Deletehttps://www.sciencedirect.com/science/article/pii/S107476132300331X
MYB orchestrates T cell exhaustion and response to checkpoint inhibition
Deletehttps://www.nature.com/articles/s41586-022-05105-1